Last checked at 21 Apr 2022 16:57
SAVILLS PLC (THE "COMPANY")
TRANSACTION IN SHARES BY DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS)
Vesting of Share Awards
Awards over ordinary shares of the Company under the Company's Deferred Share Plans have become unconditional in all respects following the end of their Deferred Period. In satisfaction of the Awards, the Trustees of the Group's Employee Benefit Trusts effected the transfer of shares, following the settlement of associated tax liabilities through the sale of shares, to Directors and PDMRs of the Company as follows:-
Director/ PDMR | Number of Shares Transferred | Number of Shares Disposed | Shareholding following this notification | Shareholding as a % of issued share capital |
Mark Ridley (Director) | 41,688 | 20,155 | 231,854 | 0.16% |
Simon Shaw (Director) | 62,189 | 62,189 | 182,579 | 0.13% |
Chris Lee (PDMR) | 13,285 | 6,423 | 119,000 | 0.08% |
David Lipson (PDMR) | 23,132 | 11,593 | 65,661 | 0.05% |
Christian Mancini (PDMR) | 10,445 | - | 147,685 | 0.10% |
Mitchell Rudin (PDMR) | 60,618 | 30,644 | 89,388 | 0.06% |
James Sparrow (PDMR) | 30,707 | 14,847 | 72,160 | 0.05% |
The share price on disposal of all shares was £10.803843 per share.
Grant of Share Awards
The Company announces that on 20 April 2022 the grant of the share based element of 2021 profit share awards has been made under the Savills Deferred Share Bonus Plan to Directors and PDMRs as follows:-
Director/ PDMR | Number of shares subject to the Savills Deferred Share Bonus Plan awarded to the Director/ PDMR on 20 April 2022 |
Mark Ridley (Director) | 90,045 |
Simon Shaw (Director) | 67,328 |
Alex Jeffrey (PDMR) | 99,473 |
Chris Lee (PDMR) | 37,442 |
Raymond Lee (PDMR) | 64,159 |
Christian Mancini (PDMR) | 16,621 |
Mitchell Rudin (PDMR) | 19,945 |
James Sparrow (PDMR) | 36,529 |
The Company announces that on 20 April 2022 the grant of an award has been made under the Savills Deferred Share Plan to a PDMR as follows:-
PDMR | Number of shares subject to the Savills Deferred Share Plan awarded to the PDMR on 20 April 2022 |
Alex Jeffrey | 45,662 |
Vesting on a sliding scale is dependent upon the satisfaction of performance criteria relating to the financial performance of Savills Investment Management, including the performance of funds managed by Savills Investment Management, over the period 2022 to 2024.
All the above awards have a Deferred Period of three years and are subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting date to reflect final and interim dividends declared during the Deferred Period.
The Company announces that on 20 April 2022 the grant of share awards under The Schedule to The Savills Deferred Share Plan to PDMRs based in the United States of America as follows:-
PDMR | Number of shares subject to the Savills Deferred Share Plan awarded to the PDMR on 20 April 2022 |
David Lipson (PDMR) | 66,485 |
Mitchell Rudin (PDMR) | 66,485 |
20% of Mr Lipson's award will vest on each of the five anniversaries subsequent to the date of grant subject to continued employment. 50% of Mr Rudin's award will vest from 31 December 2022 and 50% from 31 December 2023 subject to continued employment and performance. Both awards are subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting dates to reflect final and interim dividends declared during the Deferred Periods.
Resulting beneficial interests under the Savills Deferred Share Bonus Plan and Savills Deferred Share Plan further to the above notifications are as follows:
Director/ PDMR | Resulting beneficial interest under the Savills Deferred Share Bonus Plan and Savills Deferred Share Plan |
Mark Ridley (Director) | 199,417 |
Simon Shaw (Director) | 148,896 |
Alex Jeffrey (PDMR) | 347,459 |
Chris Lee (PDMR) | 61,844 |
Raymond Lee (PDMR) | 98,142 |
David Lipson (PDMR) | 101,170 |
Christian Mancini (PDMR) | 119,371 |
Mitchell Rudin (PDMR) | 110,782 |
James Sparrow (PDMR) | 91,620 |
The Company announces that on 20 April 2022 awards have been made under The Savills plc Performance Share Plan (the "Performance Share Plan") to Directors and PDMRs of the Company as follows:
Director / PDMR | Number of Shares subject to the Performance Share Plan awarded to the Director / PDMR on 20 April 2022 | Total number of shares subject to the Performance Share Plan following this notification |
Mark Ridley (Director) | 56,803 | 266,276 |
Simon Shaw (Director) | 43,397 | 211,999 |
Chris Lee (PDMR) | 22,006 | 102,780 |
The Performance Share Plan provides for the award of nil cost options or conditional awards of ordinary shares in the Company.
Awards of shares are made subject to a three-year performance period. Awards which satisfy the applicable performance criteria (as below) in the three-year performance period will then vest after an additional two-year holding period.
Awards vest subject to the satisfaction of the following performance criteria measured over the three years to 31 December 2024:
(a) one-third of the initial value of an award is subject to the Company's Total Shareholder Return ('TSR') performance measured against the TSR of the FTSE Mid 250 Index (excluding investment trusts);
(b) a further one-third of the initial value of an award is subject to Group Earnings per Share ('EPS') performance; and
(c) the final one-third of the initial value of an award is subject to the three year average Return on Capital Employed ('ROCE') of the Company.
Awards vest as follows:
(a) for the TSR linked part of an award, 25% (i.e. threshold) will vest if the Company's TSR matches Index performance, rising to 100% (i.e. maximum) if the Company's TSR outperforms the Index by 8% p.a., compound with sliding scale vesting between the two points;
(b) for the EPS growth linked part of an award, 25% (i.e. threshold) will vest if the Company's EPS growth is 6% p.a., compound rising to 100% (i.e. maximum) if the Company's EPS growth is 12% p.a., compound with sliding scale vesting between the two points; and
(c) for the ROCE linked part of an award, 25% (i.e. threshold) will vest if the Company's ROCE is 15% p.a., rising to 100% (i.e. maximum) if the Company's ROCE is 25% p.a. or more; and with straight-line vesting between the two points.
The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.
1. | Details of the Director/ PDMR
| ||
(a) | Name | 1. Mark Ridley 2. Simon Shaw 3. Alex Jeffrey 4. Chris Lee 5. Raymond Lee 6. David Lipson 7. Christian Mancini 8. Mitchell Rudin 9. James Sparrow
| |
2. | Reason for the notification
| ||
(a) | Position/ status | 1. Group Chief Executive/ Director 2. Group Chief Financial Officer/ Director 3. Chief Executive Officer - Savills Investment Management/ PDMR 4. Group Legal Director and Company Secretary/ PDMR 5. Chief Executive - Hong Kong, Macau and Greater China/ PDMR 6. President - Savills North America/ PDMR 7. Chief Executive Officer Asia Pacific (ex-Greater China)/ PDMR 8. President, Savills North America/ PDMR 9. CEO, Savills UK & EMEA/ PDMR
| |
(b) | Initial notification/ Amendment
| Initial notification | |
3. | Details of the issuer
| ||
(a) | Name | Savills plc
| |
(b) | LEI | 213800WXICGMBWHTA933
| |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||
(a) | Description of the Financial Instrument
| Savills plc Ordinary Shares of 2.5p each | |
(b) | Identification code of the Financial Instrument
| GB00B135BJ46 | |
(c) | Nature of the transaction
| 1) Vesting of awards under the Company's Deferred Share Plans and sale of resultant shares 2) Grant of awards over Ordinary Shares in accordance with the Company's Deferred Share Bonus Plan and Deferred Share Plan 3) Grant of awards over Ordinary Shares in accordance with the Company's Performance Share Plan
| |
(d) | Price(s) and volume(s)
| Price(s) | Volume(s)
|
1) Acquisition £nil per share
Disposal £10.803843 per share | 1. 41,688 2. 62,189 3. n/a 4. 13,285 5. n/a 6. 23,132 7. 10,445 8. 60,618 9. 30,707
1. 20,155 2. 62,189 3. n/a 4. 6,423 5. n/a 6. 11,593 7. n/a 8. 30,644 9. 14,847
| ||
2) £nil per share | 1. 90,045 2. 67,328 3. 145,135 4. 37,442 5. 64,159 6. 66,485 7. 16,621 8. 86,430 9. 36,529
| ||
3) £nil per share | 1. 56,803 2. 43,397 3. n/a 4. 22,006 5. n/a 6. n/a 7. n/a 8. n/a 9. n/a
| ||
(e) | Aggregated information
- Aggregated volume - Price
| N/A
| |
(f) | Date of the transaction
| 20 April 2022 | |
(g) | Place of the transaction
| Outside a trading venue | |
Name of contact and telephone number for queries:
Chris Lee
Group Legal Director & Company Secretary
020 3107 5444
21 April 2022